#1 Clinical Trials Search in Europe

Pancreas Powder

This article explores the use of Pancreas Powder, also known as pancreatin or pancreatic enzyme replacement therapy (PERT), in clinical trials for various digestive disorders. These trials aim to assess the effectiveness and acceptability of different formulations of Pancreas Powder in treating conditions such as cystic fibrosis, pancreatic exocrine insufficiency, and complications following pancreatic surgery.

Table of Contents

What is Pancreas Powder?

Pancreas powder, also known as pancreatin or pancreatic enzyme replacement therapy (PERT), is a medical treatment containing a mixture of digestive enzymes[1]. These enzymes are normally produced by the pancreas and are essential for proper digestion of food. The main components of pancreas powder include:

  • Lipase: helps digest fats
  • Amylase: helps digest carbohydrates
  • Protease: helps digest proteins

Pancreas powder is derived from pig pancreas and is formulated into various pharmaceutical products, such as Creon and Kreon[2].

Medical Conditions Treated

Pancreas powder is primarily used to treat pancreatic exocrine insufficiency (PEI), a condition where the pancreas doesn’t produce enough digestive enzymes. PEI can occur in several medical conditions, including:

  • Cystic fibrosis: A genetic disorder affecting the lungs and digestive system[1]
  • Pancreatic cancer: Particularly in patients with unresectable (inoperable) tumors[2]
  • Chronic pancreatitis: Long-term inflammation of the pancreas
  • After pancreatic surgery: Such as total pancreatectomy (removal of the pancreas)[3]

How Pancreas Powder Works

When taken orally with meals, pancreas powder supplements the digestive enzymes that the body is lacking. This helps in the breakdown and absorption of nutrients from food, particularly fats, proteins, and carbohydrates. The enzymes in pancreas powder are protected by a special coating that allows them to pass through the stomach acid and reach the small intestine, where they become active and aid in digestion[1].

Dosage and Administration

The dosage of pancreas powder varies depending on the specific product and the patient’s condition. Generally, it is taken with every meal and snack. For example:

  • For Creon, doses may range from 10,000 to 75,000 lipase units per meal, depending on the severity of pancreatic insufficiency[1]
  • Some patients may require doses higher than 70,000 units per main meal[3]

It’s crucial to follow your doctor’s instructions regarding dosage and timing of administration. Typically, pancreas powder should be taken at the beginning of each meal or snack.

Benefits of Pancreas Powder

Pancreas powder can provide several benefits for patients with pancreatic exocrine insufficiency:

  • Improved digestion and absorption of nutrients
  • Weight gain or maintenance in patients experiencing weight loss
  • Reduction in symptoms such as abdominal pain, bloating, and diarrhea
  • Better nutritional status, which may improve overall health and quality of life
  • In cancer patients, it may help improve tolerance to chemotherapy[2]

Potential Side Effects

While pancreas powder is generally well-tolerated, some patients may experience side effects. These can include:

  • Nausea
  • Abdominal discomfort
  • Constipation
  • Allergic reactions (rare)

It’s important to discuss any side effects with your healthcare provider. They may adjust your dosage or recommend ways to manage these effects[1].

Ongoing Research

Several clinical trials are currently underway to further investigate the benefits and optimal use of pancreas powder:

  • A study is evaluating patient acceptability of a new formulation of Creon containing pancreas powder gastro-resistant pellets in patients with cystic fibrosis[1]
  • Another trial is assessing the role of pancreatic enzyme replacement therapy in patients with unresectable pancreatic cancer, looking at its impact on weight, nutritional status, and quality of life[2]
  • Research is also being conducted on the use of pancreas powder in patients who have undergone total pancreatectomy, to determine optimal dosing strategies[3]

These ongoing studies aim to improve treatment strategies and outcomes for patients requiring pancreatic enzyme replacement therapy.

Aspect Details
Study Types Open-label, single-arm, multicenter, randomized controlled trials
Conditions Studied Cystic fibrosis with pancreatic exocrine insufficiency, unresectable pancreatic cancer with PEI, post-pancreatic surgery PEI
Main Objectives Evaluate acceptability of new formulations, assess impact on body weight and nutrition, investigate effects on digestive symptoms
Key Endpoints Changes in body weight, nutritional parameters, quality of life, digestive symptoms, dosage requirements
Dosage Forms Gastro-resistant capsules, gastro-resistant granules
Study Durations Ranging from 8 days to 6 months
Patient Age Groups Adults (18 years and older)
Safety Monitoring Adverse events, local tolerability, vital signs

FAQ

  • What is Pancreas Powder? Pancreas Powder, also known as pancreatin or pancreatic enzyme replacement therapy (PERT), is a mixture of digestive enzymes used to treat conditions where the pancreas doesn't produce enough enzymes for proper digestion.
  • What conditions are being studied with Pancreas Powder? Clinical trials are investigating the use of Pancreas Powder for conditions such as cystic fibrosis with pancreatic exocrine insufficiency, pancreatic exocrine insufficiency in patients with unresectable pancreatic cancer, and pancreatic exocrine insufficiency following pancreatic surgery.
  • How is Pancreas Powder administered? Pancreas Powder is typically administered orally in the form of capsules or gastro-resistant granules. The dosage and frequency depend on the specific condition being treated and the individual patient's needs.
  • What are the main goals of these clinical trials? The main goals of these trials include evaluating the acceptability of new formulations, assessing the impact on body weight and nutritional status, investigating the effects on digestive symptoms, and determining the appropriate dosage for different patient groups.
  • Are there any side effects associated with Pancreas Powder? While specific side effects are not mentioned in the trial data, the studies are monitoring for adverse events and local tolerability. Patients with known allergies to pancreatin or its components are typically excluded from these trials.

Ongoing Clinical Trials on Pancreas Powder

  • Study on Pancreatic Enzyme Replacement Therapy for Adults with Pancreatic Exocrine Insufficiency After Pancreatic Surgery

    Recruiting

    3 1 1 1
    Investigated drugs:
    Germany Poland Spain

  • Study on Pancreas Powder for Digestive Issues in Patients with Unresectable Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    France Italy Spain Sweden

  • Study on the Effect of Pancreatic Enzyme Replacement Therapy with Pancreas Powder in Patients with Pancreatic Exocrine Insufficiency After Total Gastrectomy

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Poland Portugal Spain

  • Study on the Acceptability of Pancreas Powder for Patients with Cystic Fibrosis and Pancreatic Exocrine Insufficiency

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Pancreatic Exocrine Insufficiency (PEI): A condition where the pancreas doesn't produce enough digestive enzymes, leading to poor digestion and absorption of nutrients.
  • Cystic Fibrosis (CF): A genetic disorder that affects the lungs and digestive system, often causing thick, sticky mucus to build up in various organs.
  • Gastro-resistant: A property of medication that allows it to pass through the stomach without being broken down, releasing its contents in the intestines.
  • Lipase: An enzyme that breaks down fats in the digestive system.
  • Pancreatin: A mixture of digestive enzymes produced by the pancreas, including lipase, amylase, and protease.
  • PERT: Pancreatic Enzyme Replacement Therapy, a treatment using enzymes to help digest food in people with pancreatic insufficiency.
  • Unresectable Pancreatic Cancer: Pancreatic cancer that cannot be completely removed through surgery.
  • Total Pancreatectomy: Surgical removal of the entire pancreas, often performed to treat severe pancreatic conditions.
  • Clinical Global Impression (CGI): A rating scale used by healthcare providers to assess the overall severity of a patient's condition and response to treatment.
  • Quality of Life (QoL): A measure of an individual's overall well-being and ability to function in daily life.

References

  1. http://clinicaltrials.eu/trial/study-on-the-acceptability-of-pancreas-powder-for-patients-with-cystic-fibrosis-and-pancreatic-exocrine-insufficiency/
  2. http://clinicaltrials.eu/trial/study-on-pancreas-powder-for-digestive-issues-in-patients-with-unresectable-pancreatic-cancer/
  3. http://clinicaltrials.eu/trial/study-on-pancreatic-enzyme-replacement-therapy-for-adults-with-pancreatic-exocrine-insufficiency-after-pancreatic-surgery/